Novel use of a CLIA-certified CDKN2C loss assay in sporadic medullary thyroid carcinoma.
Surgery（2020）
Key words
cdkn2c,clinical laboratory improvements amendments,thyroid,cyclin-dependent
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined